Clin2
NCT05867849Possibly a fitRecruiting

Cannabidiol treatment for bipolar depression symptoms

Bipolar Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests whether cannabidiol (CBD) can reduce symptoms of bipolar depression. You may be eligible if you have bipolar I or II and a current depressive episode while staying on approved mood-stabilizing or antipsychotic medication.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
360 people
Ages
19 years to 70 years
Study type
Interventional

Who can take part

  • Ages 19 to 70 and diagnosed with bipolar I or bipolar II plus a current major depressive episode
  • Your most recent depression screening must suggest moderate-to-severe depression, and low manic symptoms
  • You must currently take a stable, “therapeutic dose” mood stabilizer or certain antipsychotics (or approved combinations)
  • You must have already tried at least one recommended bipolar-depression treatment for at least 6 weeks at adequate doses
  • You must be able to use highly effective birth control (or not have heterosexual sex) and agree not to become pregnant
  • Your other health conditions and medicines must be stable, and you must not use CBD products during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05457465Recruiting· Phase 2
Cannabidiol study for anxiety and depression in bipolar disorder

This Phase 2 study tests whether cannabidiol (CBD) can reduce anxiety and depressive symptoms in people with bipolar disorder. It may help if your mood symptoms are persistent and you’re already on stable bipolar medications.

Belmont, Massachusetts
NCT06081426Recruiting
Ketogenic diet for bipolar disorder brain study

This study looks at how a ketogenic diet (very low carb, high fat) might affect brain function in people with bipolar disorder. Participants will follow the diet and have brain scans and blood tests to see how it helps mood and energy levels.

Pittsburgh, Pennsylvania
NCT07172516Recruiting· Phase 3
Study of azetukalner vs placebo for bipolar depression

This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.

Tucson, Arizona
NCT07696871Recruiting· Phase 1/Phase 2
Cannabidiol oil for treatment-resistant depression

This trial tests if cannabidiol (CBD) oil can help people with major depression that has not improved with standard antidepressants. You will take CBD oil or a placebo while continuing your current antidepressant treatment to see if it improves your symptoms.

Tubarão, Santa Catarina
NCT07121894Recruiting
Ketogenic diet for bipolar depression

This study tests whether a strict low-carbohydrate, high-fat (ketogenic) diet can improve symptoms of depression in people with bipolar disorder. Participants will receive dietary guidance and support to help them follow the diet for several weeks.

Rochester, Minnesota
NCT07494305Recruiting· Phase 2
Testing a new drug for bipolar depression

This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.

Bentonville, Arkansas

Hear when a new Bipolar Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.